Nomura Holdings’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Nomura Holdings’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-890,700	Closed	-$103M	–	2065
2023 Q3	$103M	Sell	890,700 -417,600	-32%	-$44.9M	0.29%	54
2023 Q2	$135M	Buy	+1,308,300	New	+$138M	0.36%	53
2023 Q1	–	Sell	-137,000	Closed	-$15.6M	–	1976
2022 Q4	$15.6M	Buy	+137,000	New	+$11.4M	0.06%	223

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nomura Holdings's HZNP Position: Q4 2023 in Review

Nomura Holdings sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 250,000 shares — an estimated $28.9M sold.

Nomura Holdings first reported a position in HZNP in Q1 2016 and held it in 13 quarters. The position peaked at $40.2M in Q2 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Nomura Holdings reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Nomura Holdings sold 250,000 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $28.9M.
Nomura Holdings first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2016 and held it in 13 quarters.
Nomura Holdings's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $40.2M in Q2 2023.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Nomura Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.